Newmont Corporation (NMM)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 100.92 |
|---|---|
| 52-week range | 64.68 – 115.78 |
| Return, 1 month / 3 months | −5.2% / +23.8% |
| Return, 1 year / 3 years | +52.2% / +195.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 44.9% |
| Worst drawdown (1 year) | -28.2% |
| Average daily value traded | 0.58M EUR |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Newmont Corporation is a gold mining company based in Denver, Colorado. It explores for, develops and operates gold mines and related projects in the Americas, Africa, Australia and Papua New Guinea. Alongside gold, the company produces copper, silver, zinc and lead as by-products of its mining operations. Its customers are mainly refiners, metal traders and industrial users who process and use these metals in manufacturing, jewellery and other applications around the world.
On this site Newmont Corporation appears as a stock on the Deutsche Börse Xetra (Germany), code NMM, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Newmont Corporation (NMM) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 100.92 on 27 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 195 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 52.2% and over the last three months it rose 23.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 4.2% | ||
| From 52-week high | -11.8% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.8% | ||
| 6-month return | 2.0% | ||
| 12-month return, skipping the last month | 60.5% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.2% | ||
| Liquidity | 67 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.58M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −3.6% |
|---|---|
| 1 month | −5.2% |
| 3 months | +23.8% |
| 6 months | +2.0% |
| 1 year | +52.2% |
| 3 years | +195.2% |
| 5 years | +130.3% |
Signals
| 50-day / 200-day average | 106.21 / 96.85 |
|---|---|
| Golden / death cross (60 days) | Golden, 36 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.03 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | USD 0.2313 |
| 27 May 2026 | USD 0.2313 |
| 3 Mar 2026 | USD 0.2313 |
| 26 Nov 2025 | USD 0.2224 |
| 4 Sep 2025 | USD 0.2224 |
| 27 May 2025 | USD 0.2224 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.